Antithrombin III Levels and Outcomes Among Patients With Trauma
In this cohort study of patients with trauma, antithrombin III deficiency was associated with greater injury severity, increased hemorrhage, and increased mortality, as well as fewer ventilator-free, hospital-free, and ICU-free days. Although this was an associative study, these data suggest that antithrombin III levels may be useful in the risk assessment of patients with trauma.
Authors
- Jevgenia Zilberman‐Rudenko (ORCID: https://orcid.org/0000-0001-9862-9285)
- John D. Yonge (ORCID: https://orcid.org/0000-0003-1968-7116)
- Brandon Behrens
- Mackenzie R. Cook (ORCID: https://orcid.org/0000-0001-9558-9417)
- David Martin (ORCID: https://orcid.org/0000-0003-4517-0380)
- Diane Lape
- David H. Farrell (ORCID: https://orcid.org/0000-0002-1266-0263)
- Keeley M. McConnell
- Scott Mcloud
- Andrew L. Goodman (ORCID: https://orcid.org/0000-0001-7599-3471)
- Samantha J. Underwood (ORCID: https://orcid.org/0000-0001-8565-1846)
- Martin A. Schreiber (ORCID: https://orcid.org/0000-0002-4430-6779)
Institutions
- University of Minnesota (US)
- Oregon Health & Science University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.27786
- Citations
- 9
- Primary Topic
- Trauma and Emergency Care Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.22
Funders
- Oregon Health and Science University
- CSL Behring
- Grifols
- National Institutes of Health
- Oregon Clinical and Translational Research Institute
- National Institute of General Medical Sciences